An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis
- DOI
- 10.1016/j.jiph.2022.08.016
- Published
- 2022-10
- Container
- Journal of Infection and Public Health
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jiph.2022.08.016,
title = {An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis},
author = {Mohd. Imran and Shah Alam Khan and Syed Mohammed Basheeruddin Asdaq and Mazen Almehmadi and Osama Abdulaziz and Mehnaz Kamal and Mohammed Kanan Alshammari and Lojain Ibrahim Alsubaihi and Khansa Hamza Hussain and Abrar Saleh Alharbi and A. Khuzaim Alzahrani},
year = {2022},
journal = {Journal of Infection and Public Health},
doi = {10.1016/j.jiph.2022.08.016},
url = {https://doi.org/10.1016/j.jiph.2022.08.016}
}RIS
TY - JOUR TI - An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis AU - Mohd. Imran AU - Shah Alam Khan AU - Syed Mohammed Basheeruddin Asdaq AU - Mazen Almehmadi AU - Osama Abdulaziz AU - Mehnaz Kamal AU - Mohammed Kanan Alshammari AU - Lojain Ibrahim Alsubaihi AU - Khansa Hamza Hussain AU - Abrar Saleh Alharbi AU - A. Khuzaim Alzahrani PY - 2022 JO - Journal of Infection and Public Health DO - 10.1016/j.jiph.2022.08.016 UR - https://doi.org/10.1016/j.jiph.2022.08.016 ER -
APA
Imran, M., Khan, S. A., Asdaq, S. M. B., Almehmadi, M., Abdulaziz, O., Kamal, M., Alshammari, M. K., Alsubaihi, L. I., Hussain, K. H., Alharbi, A. S., & Alzahrani, A. K. (2022). An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2022.08.016
Source records
- crossref · retrieved 2026-09-26T10:24:24.645Z